Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Considerations for PCV13 use among adults ≥65 years old and a summary of the evidence to recommendations framework
Filetype[PDF-643.45 KB]


Details:
  • Supporting Files:
    No Additional Files
    1. Pneumococcal vaccines
      Personal Author:
      Lee, Grace M.
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
      Published Date:
      June 26, 2019
      Series:
      ACIP meeting Pneumococcal Vaccines
      Description:
      Pneumococcal-1-Lee-508.pdf
      File Type:
      Filetype[PDF - 284.23 KB]
You May Also Like:
  1. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
    Personal Author:
    Matanock, Almea; Lee, Grace; Gierke, Ryan; Kobayashi, Miwako; Leidner, Andrew; Pilishvili, Tamara;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    November 22 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(46):1069-1075
    Description:
    Two pneumococcal vaccines are currently licensed for use in adults in the United States: a 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Pfizer, Inc.]) and a 23-valent pneumococcal polysaccharide vaccine (PPSV23 [Pneumovax 23, Merck an...
    File Type:
    Filetype[PDF - 392.16 KB]
  2. Pneumococcaldisease and pneumococcal vaccines
    Personal Author:
    Strikas, Raymond
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division.
    Published Date:
    September 18, 2019
    Series:
    Pink book webinar series ; chapter 17
    Epidemiology and prevention of vaccine preventable diseases webinar series
    Description:
    This online series of 15 webinars provides an overview of the principles of vaccination, general recommendations, immunization strategies for providers, and specific information about vaccine-preventable diseases and the vaccines that prevent them. E...
    File Type:
    Filetype[PDF - 3.32 MB]
  3. Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years—Zimbabwe, 2010–2016
    Personal Author:
    Dondo, Vongai; Mujuru, Hilda; Nathoo, Kusum; Jacha, Vengai; Tapfumanei, Ottias; Chirisa, Priscilla; Manangazira, Portia; Macharaga, John; de Gouveia, Linda; Mwenda, Jason M; Katsande, Regis; Weldegebriel, Goitom; Pondo, Tracy; Matanock, Almea; Lessa, Fernanda C;
    Published Date:
    September 05 2019
    Source:
    Clin Infect Dis. 2019; 69(Suppl 2):S72-S80
    Description:
    BackgroundStreptococcus pneumoniae is a leading cause of pneumonia and meningitis in children aged <5 years. Zimbabwe introduced 13-valent pneumococcal conjugate vaccine (PCV13) in 2012 using a 3-dose infant schedule with no booster dose or catch-up ...
    File Type:
    Filetype[PDF - 2.66 MB]
  4. Pneumococcal vaccines
    Personal Author:
    Lee, Grace M.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
    Published Date:
    June 26, 2019
    Series:
    ACIP meeting Pneumococcal Vaccines
    Description:
    Pneumococcal-1-Lee-508.pdf
    File Type:
    Filetype[PDF - 284.23 KB]
  5. Factors associated with fatal cases of acute respiratory infection (ARI) among hospitalized patients in Guatemala
    Personal Author:
    Tomczyk, Sara; McCracken, John P.; Contreras, Carmen Lucia; Lopez, Maria Renee; Bernart, Chris; Moir, Juan Carlos; Escobar, Kenneth; Reyes, Lisette; Arvelo, Wences; Lindblade, Kim; Peruski, Leonard; Bryan, Joe P.; Verani, Jennifer R.;
    Published Date:
    May 03 2019
    Source:
    BMC Public Health. 19
    Description:
    BackgroundAcute respiratory infection (ARI) is an important cause of mortality in children and adults. However, studies assessing risk factors for ARI-related deaths in low- and middle-income settings are limited. We describe ARI-related death and as...
    File Type:
    Filetype[PDF - 736.28 KB]